States Sue Insys Over Opioid Marketing
Massachusetts reaching a settlement with Insys Therapeutics over the company’s marketing of its opioid, Subsys, may have opened the door to more lawsuits. According to The Wall Street Journal, New Jersey has now filed a lawsuit against Insys claiming that the company marketed its painkiller for widespread use when it was approved to treat serious cancer pain. New Jersey is claiming that the company is responsible for a woman who died after being prescribed Subsys for fibromyalgia.
Rolling Back the Birth Control Mandate
The requirement that employers cover birth control in health insurance plans is being rolled back. The Trump administration announced it would allow for more exemptions for those who cite moral or religious objections to providing coverage of birth control, reported The New York Times. The Trump administration, in writing the new rules, notes that the Affordable Care Act actually does not explicitly require that birth control is covered. Getting rid of the requirement could cause hundreds of thousands of women to lose access to free birth control.
Virginians Eligible for Medicaid Staying Uninsured
Approximately 90,000 Virginians are eligible for healthcare assistance programs, but have remained uninsured. A new report has found that of those eligible, 60,000 are children who can be signed up for Medicaid or the state’s program for children. In 2015, there were a total of 747,000 uninsured people in Virginia. The state has not expanded the Medicaid program, which would make even more people eligible for coverage.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Patient Navigation in Oncology at Heart of Priority Health White House Visit
April 24th 2024On March 27, Priority Health's president and CEO, Praveen Thadani participated in a discussion on how to expand and optimize patient navigation services in oncology care, as part of the Cancer Moonshot initiative.
Read More